Drawing for 3DM 3-D MATRIX MEDICAL TECHNOLOGY

USPTO serial 90515880

3DM 3-D MATRIX MEDICAL TECHNOLOGY

Reviewed by CopyMark Law Group

Reg. 6792138Status 700Registered
Filing date
Status date
Registration date
Jul 19, 2022
Examiner
STOIDES, KATHERINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with 3DM 3-D MATRIX MEDICAL TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Constantine LINNIK

Constantine LINNIK IP SUPRA, PLLCPO BOX 381381CAMBRIDGE, MA 02238UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, synthetic peptide hydrogels for medical purposes for use as an absorbable bulking agent, hemostatic agent, wound healing agent, agent preventing adhesion and scar tissue formation, and for tissue protection in general, or for use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical procedures, including endoscopic surgeries; medical preparations for the treatment of disorders and conditions in ear, nose and throat or gastrointestinal tract; medical preparations for use as an embolic agent in treatment of cancer; medical preparations for uplifting or separating tissues during surgery; syringes pre-filled with synthetic peptide hydrogel solution for medical purposes for use as an absorbable bulking agent, hemostatic agent, wound healing agent, agent preventing adhesion and scar tissue formation, and for tissue protection in general, or for use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical procedures, including endoscopic surgeries; excluding from any of the aforementioned a coating to provide a porous surface for bony attachment to an orthopedic implantACTIVEJun 1, 2020
044Providing a website featuring health and medical information about medical products, specifically about self-assembling peptide hydrogels and their medical applicationsACTIVEMar 26, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 19, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 19, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 3, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 3, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 30, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 30, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 30, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 3, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 2, 2022ALIEASSIGNED TO LIE—
Feb 7, 2022DOCKASSIGNED TO EXAMINER—
Feb 1, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Feb 1, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 3, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2021DOCKASSIGNED TO EXAMINER—
May 12, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance